Is VACN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of VACN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VACN (CHF343.2) is trading below our estimate of fair value (CHF530.89)
Significantly Below Fair Value: VACN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VACN?
Key metric: As VACN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for VACN. This is calculated by dividing VACN's market cap by their current
earnings.
What is VACN's PE Ratio?
PE Ratio
51.4x
Earnings
CHF 200.11m
Market Cap
CHF 10.41b
VACN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: VACN is expensive based on its Price-To-Earnings Ratio (51.4x) compared to the European Machinery industry average (17.5x).
Price to Earnings Ratio vs Fair Ratio
What is VACN's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
VACN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
51.4x
Fair PE Ratio
34.1x
Price-To-Earnings vs Fair Ratio: VACN is expensive based on its Price-To-Earnings Ratio (51.4x) compared to the estimated Fair Price-To-Earnings Ratio (34.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst VACN forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
CHF 343.20
CHF 420.53
+22.5%
16.1%
CHF 550.00
CHF 325.00
n/a
15
Nov ’25
CHF 363.90
CHF 423.20
+16.3%
16.0%
CHF 550.00
CHF 325.00
n/a
15
Oct ’25
CHF 424.60
CHF 473.67
+11.6%
18.0%
CHF 700.00
CHF 350.00
n/a
15
Sep ’25
CHF 437.20
CHF 485.00
+10.9%
16.3%
CHF 700.00
CHF 370.00
n/a
15
Aug ’25
CHF 440.30
CHF 475.75
+8.1%
17.7%
CHF 700.00
CHF 343.00
n/a
16
Jul ’25
CHF 505.80
CHF 467.40
-7.6%
18.7%
CHF 625.00
CHF 322.00
n/a
15
Jun ’25
CHF 486.60
CHF 456.31
-6.2%
18.2%
CHF 625.00
CHF 322.00
n/a
16
May ’25
CHF 462.70
CHF 456.31
-1.4%
18.2%
CHF 625.00
CHF 322.00
n/a
16
Apr ’25
CHF 467.30
CHF 428.89
-8.2%
17.1%
CHF 585.00
CHF 322.00
n/a
16
Mar ’25
CHF 447.70
CHF 396.08
-11.5%
20.4%
CHF 585.00
CHF 278.00
n/a
16
Feb ’25
CHF 409.30
CHF 393.64
-3.8%
20.2%
CHF 585.00
CHF 278.00
n/a
16
Jan ’25
CHF 421.50
CHF 367.28
-12.9%
17.7%
CHF 500.00
CHF 278.00
n/a
16
Dec ’24
CHF 403.80
CHF 348.71
-13.6%
17.5%
CHF 500.00
CHF 259.00
n/a
16
Nov ’24
CHF 322.00
CHF 337.30
+4.8%
14.1%
CHF 440.00
CHF 259.00
CHF 363.90
15
Oct ’24
CHF 329.00
CHF 338.50
+2.9%
16.9%
CHF 440.00
CHF 259.00
CHF 424.60
12
Sep ’24
CHF 355.10
CHF 339.77
-4.3%
16.1%
CHF 440.00
CHF 259.00
CHF 437.20
13
Aug ’24
CHF 370.10
CHF 336.67
-9.0%
16.5%
CHF 440.00
CHF 259.00
CHF 440.30
12
Jul ’24
CHF 370.00
CHF 335.77
-9.3%
17.2%
CHF 440.00
CHF 259.00
CHF 505.80
13
Jun ’24
CHF 372.50
CHF 327.08
-12.2%
15.7%
CHF 412.00
CHF 259.00
CHF 486.60
12
May ’24
CHF 313.30
CHF 314.83
+0.5%
15.9%
CHF 412.00
CHF 259.00
CHF 462.70
12
Apr ’24
CHF 328.20
CHF 308.73
-5.9%
15.3%
CHF 405.00
CHF 249.00
CHF 467.30
11
Mar ’24
CHF 285.60
CHF 298.82
+4.6%
9.9%
CHF 350.00
CHF 249.00
CHF 447.70
11
Feb ’24
CHF 288.00
CHF 298.82
+3.8%
9.9%
CHF 350.00
CHF 249.00
CHF 409.30
11
Jan ’24
CHF 252.80
CHF 290.36
+14.9%
9.2%
CHF 325.00
CHF 249.00
CHF 421.50
11
Dec ’23
CHF 264.80
CHF 278.09
+5.0%
9.3%
CHF 320.00
CHF 230.00
CHF 403.80
11
Nov ’23
CHF 228.80
CHF 278.18
+21.6%
10.1%
CHF 322.00
CHF 230.00
CHF 322.00
11
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.